Ligand validation:6TXI

LFA: EICOSANE

LFA is a Ligand Of Interest in 6TXI designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6TXI_LFA_B_206	49%	86%	0.135	0.881	0.47	0.25	-	-	2	0	100%	1
6TXI_LFA_F_203	44%	92%	0.168	0.894	0.43	0.12	-	-	2	0	100%	1
6TXI_LFA_G_204	41%	86%	0.138	0.85	0.48	0.25	-	-	3	0	100%	1
6TXI_LFA_C_205	36%	90%	0.162	0.852	0.32	0.29	-	-	2	0	100%	1
6TXJ_LFA_B_211	27%	92%	0.242	0.893	0.22	0.31	-	-	1	0	100%	1
6SU4_LFA_X_616	66%	100%	0.113	0.917	0.09	0.1	-	-	0	0	100%	1
7AKY_LFA_A_403	58%	99%	0.088	0.911	0.08	0.14	-	-	5	0	75%	0.75
8QLF_LFA_A_408	55%	100%	0.083	0.933	0.1	0.06	-	-	1	0	55%	0.55
6RF6_LFA_A_307	50%	79%	0.101	0.904	0.23	0.62	-	-	0	0	70%	0.7
4HYJ_LFA_B_302	48%	74%	0.164	0.962	0.2	0.79	-	-	1	0	70%	0.7

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.